טוען...
Semapimod sensitizes glioblastoma tumors to ionizing radiation by targeting microglia.
Glioblastoma is the most malignant and lethal form of astrocytoma, with patients having a median survival time of approximately 15 months with current therapeutic modalities. It is therefore important to identify novel therapeutics. There is mounting evidence that microglia (specialized brain-reside...
שמור ב:
| Main Authors: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Public Library of Science (PLoS)
2014-01-01
|
| סדרה: | PLoS ONE |
| גישה מקוונת: | http://europepmc.org/articles/PMC4015930?pdf=render |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|